Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28375452.
- Also identified by DOI 10.1093/rheumatology/kew417 and PMC identifier 5850311.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This review summarizes traditional and emerging therapies for SLE. Evidence suggests that the heterogeneity of SLE is a crucial aspect contributing to the failure of large clinical trials for new targeted therapies. A clearer understanding of the mechanisms driving disease pathogenesis combined with recent advances in medical science are predicted to enable accelerated progress towards improved SLE diagnosis and personalized approaches to treatment.
Medical subject headings
- Antirheumatic Agents
- Glucocorticoids
- Immunosuppressive Agents